These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3498741)

  • 1. Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.
    Ratnoff OD; Emanuelson MM; Ziats NP
    J Clin Invest; 1987 Oct; 80(4):1180-9. PubMed ID: 3498741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII).
    Niwano H; Embury PB; Greenberg BD; Ratnoff OD
    J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.
    Ratnoff OD; Gleich GJ; Shurin SB; Kazura J; Everson B; Embury P
    Am J Hematol; 1993 Jan; 42(1):138-45. PubMed ID: 8416290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some cardiovascular and hematological changes induced in the rat by activation of Hageman factor with ellagic acid.
    Damas J; Remacle-Volon G; Adam A
    Adv Exp Med Biol; 1989; 247A():461-5. PubMed ID: 2603812
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.
    Rehmus EH; Greene BM; Everson BA; Ratnoff OD
    J Clin Invest; 1987 Aug; 80(2):516-21. PubMed ID: 3038961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol).
    Laurel MT; Ratnoff OD; Everson B
    J Lab Clin Med; 1992 May; 119(5):580-5. PubMed ID: 1374787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae.
    Foster CB; Flanigan TP; Kazura JW; Dumenco LL; Ratnoff OD
    J Lab Clin Med; 1991 May; 117(5):344-52. PubMed ID: 1902251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HMG-I protein from human endothelial cells apparently is secreted and impairs activation of Hageman factor (factor XII).
    Donaldson VH; Wagner CJ; Mitchell BH; Mandle R
    Proc Assoc Am Physicians; 1998; 110(2):140-9. PubMed ID: 9542770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the activation of Hageman factor (factor XII) by human vascular endothelial cell culture supernates.
    Ratnoff OD; Everson B; Embury P; Ziats NP; Anderson JM; Emanuelson MM; Malemud CJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10740-3. PubMed ID: 1961740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments by popcorn inhibitor.
    Ratnoff OD; Moneme V
    Proc Soc Exp Biol Med; 1981 Feb; 166(2):297-9. PubMed ID: 7208489
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
    Koenig JM; Chahine A; Ratnoff OD
    J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments.
    Ratnoff OD
    Blood; 1981 Jan; 57(1):55-8. PubMed ID: 7448415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.